January 17, 2024

Norcros: Strong Half-Year Report, Strategic Progress, and Investment Potential

Discover why Norcros (LON:NXR) is a strong investment opportunity with a 50% upside potential. Despite revenue pressures, the company showed resilience and strategic progress, leading to increased operating margins and record profits in the UK. Find out more about their consistent growth strategy and robust market positioning, making Norcros an attractive proposition for long-term investors...

Safestore deliver a resilient year of significant strategic and operational progress

Safestore Holdings plc announces its results for the year ended October 31, 2023, showing strong financial performance and strategic progress...

Mitchells & Butlers reports Strong Sales Growth and Outlook for the year ahead

Mitchells & Butlers plc has reported strong sales growth in its first quarter, with like-for-like sales up 7.7% and total sales up 9.7%...

Wizz Air fully compliant with customer claims, confirms CAA

Wizz Air Holdings Plc has successfully complied with the UK's Civil Aviation Authority after disruptions in 2022, investing £90m to improve operations...

Pearson 2023 trading update: Strong performance in Assessment & Qualifications and English Language Learning

Pearson reports strong financial performance in its latest trading update, with a 5% sales growth and a 30% increase in profit...

Likewise Group extremely well positioned to accelerate growth during 2024

Likewise Group plc has announced the full payment of £3,855,000 to Valley Wholesale Carpets, resulting in positive impact on profitability and cash flow...

Tirupati Graphite raises £1,045,000 for working capital and production optimisation

Tirupati Graphite plc has raised £1,045,000 through a private placing and subscription, with proceeds to be used for working capital and production optimisation...

Poolbeg Pharma promising results for POLB 001 in cancer immunotherapy-induced CRS

Poolbeg Pharma plc has announced promising results for POLB 001 in addressing cancer immunotherapy-induced CRS...
Search

Funds

January 17, 2023

Norcros: Strong Half-Year Report, Strategic Progress, and Investment Potential

Discover why Norcros (LON:NXR) is a strong investment opportunity with a 50% upside potential. Despite revenue pressures, the company showed resilience and strategic progress, leading to increased operating margins and record profits in the UK. Find out more about their consistent growth strategy and robust market positioning, making Norcros an attractive proposition for long-term investors...

Safestore deliver a resilient year of significant strategic and operational progress

Safestore Holdings plc announces its results for the year ended October 31, 2023, showing strong financial performance and strategic progress...

Mitchells & Butlers reports Strong Sales Growth and Outlook for the year ahead

Mitchells & Butlers plc has reported strong sales growth in its first quarter, with like-for-like sales up 7.7% and total sales up 9.7%...

Wizz Air fully compliant with customer claims, confirms CAA

Wizz Air Holdings Plc has successfully complied with the UK's Civil Aviation Authority after disruptions in 2022, investing £90m to improve operations...

Pearson 2023 trading update: Strong performance in Assessment & Qualifications and English Language Learning

Pearson reports strong financial performance in its latest trading update, with a 5% sales growth and a 30% increase in profit...

Likewise Group extremely well positioned to accelerate growth during 2024

Likewise Group plc has announced the full payment of £3,855,000 to Valley Wholesale Carpets, resulting in positive impact on profitability and cash flow...

Tirupati Graphite raises £1,045,000 for working capital and production optimisation

Tirupati Graphite plc has raised £1,045,000 through a private placing and subscription, with proceeds to be used for working capital and production optimisation...

Poolbeg Pharma promising results for POLB 001 in cancer immunotherapy-induced CRS

Poolbeg Pharma plc has announced promising results for POLB 001 in addressing cancer immunotherapy-induced CRS...
Search

Funds

January 17, 2024

FTSE 100

Funds

Day: January 17, 2024